companyprofile

Actions

Dallah Healthcare Co.

4004
DALLAH HEALTH
Add To Watchlist
In your Watchlist
Add To Watchlist
  • Main Market
  • Health Care Equipment & Svc

Stats Overview

  • Prev. Close 137.40
  • Open 137.40
  • High 137.40
  • Low 134.60
  • No. of Trades 1,533
  • Avg. Trade size* 84
  • Volume Traded 128,140
  • Value Traded (SAR) 17,421,888.60

Performance

DALLAH HEALTH
-0.60 ( -0.44% )
Compare
Index Name Index Level 1D Return
Dallah Healthcare Co. 137.40 -0.44%
Note: Prices are delayed minimum 5 minutes
  • *Average Trade Size = Cumulative / # of Trades
  • **52 Week Price Change =   (Current Price - Price year ago) / Price year ago x 100
  • Historical prices & volume traded data are adjusted to account for all corporate actions.
  • MO: Market Order

Trade Updates

Last Trade

Price
136.80
% Change
-0.44
Volume Traded
209

Best Bid

Price 135.00
Volume Traded 4

Best Offer

Price 136.80
Volume Traded 25,533

52 WEEK

High
176.00
2022/10/16
Low
77.50
2022/02/24
Change**
57.6

PERFORMANCE

Start of Year
146.4
Year ago
86.8
3 Years ago
38.82

Compare Selected

Select a Maximum of 5 Companies

Compare Selected

LoginPortletPopupv2

Actions

AddtoWatchlistv2

Actions

Add to watchlist

AnnouncmentandCorporateAction

Actions
Jump To :
  • Announcements & Corporate Actions
  • Financials
  • Shareholding
  • Peer Comparison
  • Company Profile

Announcements

  • Dallah Healthcare Co. Announces an update on Dallah Healthcare Company announces its Board resolution starting the negotiation of the purchase of all issued shares by Dr. Mohammed Rashed Alfagih Company & Partners (Associate company) which is not owned by the company.

    4004
    DALLAH HEALTH -0.44 %
    1444/06/24     17/01/2023 08:19:29
  • Dallah Healthcare Company Announces the Completion of the Procedures of the Acquisition of Shares in International Medical Center Company

    4004
    DALLAH HEALTH -0.44 %
    1444/06/23     16/01/2023 15:42:57
  • Dallah Healthcare Co. announces the results of the extraordinary general assembly meeting that included approval of a capital increase for the company (first meeting).

    4004
    DALLAH HEALTH -0.44 %
    1444/06/04     28/12/2022 08:26:29
  • Dallah Healthcare Company announces the signing of a contract for the mechanical, electrical, and finishing work of the second stage of Dallah Namar Hospital with Youssef Marroun Contracting Co.

    4004
    DALLAH HEALTH -0.44 %
    1444/06/02     26/12/2022 15:42:40
  • Dallah Healthcare Co. announces the distribution of cash dividends for second half of the fiscal year 2022

    4004
    DALLAH HEALTH -0.44 %
    1444/05/25     19/12/2022 16:04:22
View All

Corporate Actions

--
All Corporate Actions

CompanyProfilev2Financials

Actions
Jump To:
  • Announcements & Corporate Actions
  • Financials
  • Shareholding
  • Peer Comparison
  • Company Profile

Financials

  • Balance Sheet
  • Statement of Income
  • Cash Flow
  • XBRL
  • Detailed Reports and Statements
  • Annually
  • Quarterly
Balance Sheet 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Current Assets
955,071.63
815,329
510,046
486,224
Inventory
219,200.47
165,693
104,534
88,773
Investments
478,035
195,442
180,243
150,605
Fixed Assets
2,797,585.15
2,417,079
2,102,521
1,953,199
Other Assets
195,217.28
393,723
18,720
18,890
Total Assets
4,645,109.53
3,987,266
2,916,064
2,697,691
Current Liabilities
923,429.94
727,512
420,671
416,392
Non-Current Liabilities
1,625,603.77
1,410,016
973,265
680,094
Other Liabilities - - - -
Shareholders Equity
1,866,790.57
1,849,738
1,522,128
1,601,205
Total Liabilities and Shareholder Equity
4,645,109.53
3,987,266
2,916,064
2,697,691
Minority Interests
229,285.25
- - -
All Figures in Thousands Thousands Thousands Thousands
All Currency In SAR SAR SAR SAR
Last Update Date 2022-12-29 2021-03-25 2020-03-02 2019-03-07
Balance Sheet 2022-09-30 2022-06-30 2022-03-31 2021-09-30
Current Assets
1,240,482
1,042,681
1,042,348.48
970,518
Inventory
248,006
240,458
226,127.59
224,587
Investments
504,562
464,064
471,525.38
186,194
Fixed Assets
2,836,691
2,825,740
2,804,213.3
2,737,842
Other Assets
204,312
205,114
194,689.64
229,663
Total Assets
5,034,053
4,778,057
4,738,904.38
4,348,804
Current Liabilities
1,071,350
917,406
888,313.95
928,029
Non-Current Liabilities
1,744,363
1,599,994
1,663,985.22
1,323,763
Other Liabilities - - - -
Shareholders Equity
1,976,481
2,022,580
1,953,052.32
1,877,134
Total Liabilities and Shareholder Equity
5,034,053
4,778,057
4,738,904.38
4,348,804
Minority Interests
241,859
238,077
233,552.9
219,878
All Figures in Thousands Thousands Thousands Thousands
All Currency In SAR SAR SAR SAR
Last Update Date 2023-01-02 2023-01-01 2022-12-29 2021-11-08
Jump To:
  • Announcements & Corporate Actions
  • Financials
  • Shareholding
  • Peer Comparison
  • Company Profile

Shareholding Information

  • Board Of Directors
  • Foreign Ownership
  • Substantial Shareholders
Time Period
-
Search
Trading Date Shareholders Designation Shares Held Trading Day Shares Held Prev Trading Day Change
2023-01-31 طارق عثمان عبدالله القصبي Chairman 4.5151836 4.5151836 0
2023-01-31 محمد راشد محمد الفقيه Board of Directors 4.8332613 4.8332613 0
2023-01-31 احمد صالح محمد بابعير Senior Executives 0.0019502 0.0019502 0
2023-01-31 فهد عبدالله عبدالعزيز القاسم Board of Directors 0.0019502 0.0019502 0
2023-01-31 محي الدين صالح عبدالله كامل Board of Directors 0.0015612 0.0015612 0
  • The listed company (Publisher) shall be responsible for the accuracy of the published information pertaining to the ownership of the Board of Directors, Chief Executive Officer or highest executive position, and the Chief Financial Officer. The listed company shall also be responsible for updating these information thereof. Therefore, the Saudi Stock Exchange (Tadawul) shall not be liable for the information contained therein, nor for any consequences that may result from the said information.
for
subs
Jump To:
  • Announcements & Corporate Actions
  • Financials
  • Shareholding
  • Peer Comparison
  • Company Profile

Peer Comparison

  • Table
  • Graphical
Add Company

Compare Selected

Select a Maximum of 5 Companies

Company Apply
Dallah Healthcare Co.
Price 136.80
Market Cap (SAR MN) 13,363
P/E Ratio 47.09
Jump To:
  • Announcements & Corporate Actions
  • Financials
  • Shareholding
  • Peer Comparison
  • Company Profile

Company Profile

Company overview

The main core business for Dallah Health is hospitals. The company runs its two hospitals. The Hospital provides medical services for its outpatient, inpatients, specialized clinics, and hypnosis departments. Besides hospitals, Dallah health has other business activities: Dallah pharma trade manufactures and distributes the medicines. Dallah health manages and operates other hospitals and provides support services in maintenance for hospitals and medical centers. We also have investments and shares in other companies in the healthcare industry in MENA, in which Dallah health invests heavily in other companies in the health care industry.

Company History

Dallah Health is a joint stock company listed in the Saudi TADAWL since November 2012 under commercial registration: 1010128530 dated September 19 1994 under code number (4004) in the health care Sector''s main market. The company''s capital consists of ninety-seven million, six hundred eighty-one thousand and one hundred sixty-six (97,681,166) ordinary shares. With a nominal value of 10 riyals paid in full and a total value of nine hundred seventy-six million eight hundred eleven thousand six hundred sixty (976,811,660) Saudi Riyals

Company Bylaws

Click here

Equity Profile

  • Authorized Capital (SAR) 976,811,660
  • Issued Shares 97,681,166
  • Paid Capital (SAR) 976,811,660
  • Par Value/Share 10
  • Paid Up Value/Share 10

Last Update :2023-01-16

Investment limits

There are no investment limits on the company shares as per the amended Rules for Qualified Foreign Financial Institutions Investment in Listed Securities and Instructions for the Foreign Strategic Investors Ownership in Listed Companies based on company bylaw and the issued instructions by the related regulators and supervisory authorities

 

  • Company Details
  • BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
  • Date Established

    1994/09/19

  • Financial Year End

    31/12

  • Listing Date

    2012/11/17

  • External Auditors

    [KPMG]

  • ISIN CODE

    SA135G51UI10

  • Number of Employees

    -

  • Chairman

    Eng. Tarek Othman Alkasabi
    Non - Executive

    Eng. Tarek Othman Alkasabi
    • BD Session Start
      2022-10-21
      Designation
      Chairman
    • BD Session End
      2025-10-20
      Classification
      Non - Executive
  • Board of Directors

    Eng. Talal Ibrahim Al-Maiman Independent

    Eng. Talal Ibrahim Al-Maiman
    • BD Session Start
      2022-10-21
      Designation
      Board of Directors
    • BD Session End
      2025-10-20
      Classification
      Independent

    Mr. Abdullah Turki Al-Sudairy Independent

    Mr. Abdullah Turki Al-Sudairy
    • BD Session Start
      2022-10-21
      Designation
      Board of Directors
    • BD Session End
      2025-10-20
      Classification
      Independent

    Mr. Fahad Abdullah Al kassim Non - Executive

    Mr. Fahad Abdullah Al kassim
    • BD Session Start
      2022-10-21
      Designation
      Board of Directors
    • BD Session End
      2025-10-20
      Classification
      Non - Executive

    Dr. Mohammed Rashid Al-Fagih Executive

    Dr. Mohammed Rashid Al-Fagih
    • BD Session Start
      2022-10-21
      Designation
      Board of Directors
    • BD Session End
      2025-10-20
      Classification
      Executive

    Mr. Muhei Addein Saleh Kamel Deputy Chairman - Non Executive

    Mr. Muhei Addein Saleh Kamel
    • BD Session Start
      2022-10-21
      Designation
      Board of Directors
    • BD Session End
      2025-10-20
      Classification
      Deputy Chairman - Non Executive

    Mr. Amr Mohammed Kamel Non - Executive

    Mr. Amr Mohammed Kamel
    • BD Session Start
      2022-10-21
      Designation
      Board of Directors
    • BD Session End
      2025-10-20
      Classification
      Non - Executive

    Eng. Mohamed Nabil Hefni Non - Executive

    Eng. Mohamed Nabil Hefni
    • BD Session Start
      2022-10-21
      Designation
      Board of Directors
    • BD Session End
      2025-10-20
      Classification
      Non - Executive
  • Senior Executives

    Dr. Ahmad Saleh Babaeer CEO

    Dr. Ahmad Saleh Babaeer
    • BD Session Start
      2008-03-29
      Designation
      Senior Executives
    • BD Session End
      -
      Classification
      CEO

    Mr. Ali Saeed Alqahtani CFO

Mr. Ali Saeed Alqahtani
  • BD Session Start
    2021-11-14
    Designation
    Senior Executives
  • BD Session End
    -
    Classification
    CFO

Investor Relations

Contact Name:

Investor Relations

Company Address:

Nakheel building, 1157 King Fahad Road, 2nd fl., Nakheel District, Riyadh, KSA

Contact Details:

Telephone: 0112255065-5001
Fax: 0114550803
Email: IR@dallahhealth.com

Company Website:

www.dallahhealth.com


Add To Watchlist
In your Watchlist
Add To Watchlist